Yesterday I came across a Science Daily article discussing a recent study on the need to have different diagnostic criteria for the kappa and lambda types of myeloma. Apparently some patients with the lambda type go undiagnosed, based on current criteria.

Here’s the link: http://bit.ly/2GfulHf

And here’s an excerpt: “Current testing trends lean toward looking in the serum only which also can lead to problems detecting lambda-associated conditions.”

I wonder how many have had that problem…?